Search results
GSK announced the opening of a S$44 million high potency facility (HPF) in its strategic New Product Introduction site in Jurong, Singapore. The opening of the facility was officiated by Guest-of-Honour, Singapore’s Minister for Health, Mr. Ong Ye Kung, and Mr. Regis Simard, GSK’s President, Global Supply Chain.
- Search Jobs
GSK plc. Registered in England and Wales No. 3888792....
- Manufacturing and Supply
Manufacturing and Supply - Singapore | GSK
- Media Contacts
Media Contacts - Singapore | GSK
- Quarterly Results
GSK plc. Registered in England and Wales No. 3888792....
- London (Rns)
London (Rns) - Singapore | GSK
- Analyst Consensus
GSK neither endorses, concurs nor accepts responsibility...
- Search Jobs
o GSK has three manufacturing sites in Singapore at Quality Road, Jurong, and Tuas. The anticipated closure of Quality Road will not impact our operations at Jurong and Tuas. o Latest investments highlights: GSK opened new state-of-the-art manufacturing facilities at the Jurong Site following a S$130m investment in July 2019. This
- 147KB
- 2
Nov 18, 2022 · GSK invested S$44 million to produce a key ingredient for antibody drug conjugates (ADCs) to treat cancer at its New Product Introduction site in Jurong. The facility is the first in Singapore to handle highly potent cytotoxic components in ADCs and marks 40 years of GSK's presence in Singapore.
GSK invests S$44m in a high potency manufacturing and testing facility in Singapore to produce a key ingredient for antibody drug conjugates (ADCs). The facility is the first in Singapore to handle highly potent cytotoxic components and will launch new products more quickly.
Jul 5, 2019 · The new facility is part of GSK's global supply chain and a testbed for advanced manufacturing technology. It was developed with the Economic Development Board under the Singapore Manufacturing Roadmap.
Nov 17, 2022 · Located in Jurong, the $44 million high-potency facility is also the first in Singapore, strengthening the site’s capabilities to meet increasing demand for oncology treatments around the...
PHARMACEUTICAL giant GlaxoSmithKline (GSK) unveiled a new, fully automated continuous manufacturing facility and an expanded production building at its Jurong site on Friday, worth a total of S$130 million.
